This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Epidemiology

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Diabetic retinopathy (DR) is prevalent in around 35% of people with diabetes (1).

  • Global prevalence of proliferative DR (PDR) among patients with diabetes is estimated to be 7.5%.
  • Prevalence of any DR and PDR was higher in those with type 1 diabetes, compared to those with type 2 diabetes (2).

DR is the leading cause of blindness among the working-age group (20-64 years) in developed countries.

  • The prevalence of blindness caused by DR is increasing despite the availability of effective treatment.
    • In England, Wales, and Scotland between February 1999 and March 2000, the number of patients on the blind register as a result of diabetic retinopathy in working age group was 2.05 per 100,000 population compared with 1.26 per 100,000 population in 1990-1 (3).

Around one third of DR patients are afflicted with vision-threatening diabetic retinopathy (VTDR), defined as severe non-proliferative DR or proliferative DR (PDR) or the presence of diabetic macular oedema (DME).

  • PDR is the most common vision threatening lesion especially in type 1 diabetes patients.
  • DME is responsible for most of the visual loss experienced by patients with diabetes as it remains the major cause of vision loss in the highly prevalent type 2 diabetes (2).

Reference:

  1. Das A et al. New treatments for diabetic retinopathy. Diabetes Obes Metab. 2015;17(3):219-30.
  2. Lee R et al. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond). 2015; 2: 17.
  3. Ockrim Z, Yorston D. Managing diabetic retinopathy. BMJ. 2010;341:c5400.

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.